Does the HFA/ICOS tool overestimate the risk of cardiovascular toxicities in oncologic patients scheduled to receive anti-VEGF agents?

No abstract available
Source: Journal of Cardiovascular Medicine - Category: Cardiology Tags: Research letters Source Type: research